Owner Eli Lilly and Company

Inventors Micanovic, Radmilla; Tschang, ShengHung Rainbow; Glaesner, Wolfgang

Agent Wrays

Pub. Number AU-B-2002226897

PCT Pub. Number WO02/46227

Priority 60/251,954 07.12.00 US

Filing date 29 November 2001

Wipo publication date 18 June 2002

Acceptance publication date 25 October 2007

C12N 15/02 (2006.01) Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07K 14/605 (2006.01) Peptides having more than 20 amino acids

C07K 14/76 (2006.01) Peptides having more than 20 amino acids

C07K 14/765 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 19/00 (2006.01) Hybrid peptides

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione